Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Liver Cancer
Interventions
PROCEDURE

Blood draw

A two-time blood draw: one prior to cancer treatment, the second after cancer treatment. Total amount of blood approximately 8 teaspoons (40mL).

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
collaborator

Northwestern University Feinberg School of Medicine

OTHER

lead

Northwestern University

OTHER

NCT00866957 - Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC) | Biotech Hunter | Biotech Hunter